MeSH term
Frequency | Condition_Probility | Humans | 38 | 0.0 |
Amino Acid Sequence | 9 | 0.0 |
Animals | 11 | 0.0 |
Base Sequence | 15 | 0.0 |
Catalytic Domain | 2 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
*DNA Glycosylases | 28 | 38.0 |
Kinetics | 4 | 0.0 |
Mice | 6 | 0.0 |
Molecular Sequence Data | 16 | 0.0 |
Research Support, Non-U.S. Gov't | 26 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
N-Glycosyl Hydrolases/metabolism | 2 | 11.0 |
Reference Standards | 2 | 0.0 |
Binding Sites | 4 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
DNA Repair | 5 | 0.0 |
Deoxyuracil Nucleotides/metabolism | 2 | 40.0 |
Endodeoxyribonucleases/metabolism | 2 | 6.0 |
Escherichia coli/enzymology/genetics | 2 | 3.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Cell Extracts | 2 | 1.0 |
DNA Damage | 2 | 0.0 |
DNA Replication | 2 | 0.0 |
Mutation | 2 | 0.0 |
N-Glycosyl Hydrolases/*physiology | 2 | 40.0 |
Research Support, U.S. Gov't, P.H.S. | 13 | 0.0 |
Cell Line | 3 | 0.0 |
Virus Replication/*physiology | 2 | 3.0 |
Blotting, Western | 2 | 0.0 |
Cells, Cultured | 5 | 0.0 |
DNA Glycosylases | 2 | 11.0 |
DNA Repair/*genetics | 2 | 0.0 |
DNA-(Apurinic or Apyrimidinic Site) Lyase | 3 | 4.0 |
Deoxyribonuclease IV (Phage T4-Induced) | 3 | 6.0 |
Male | 3 | 0.0 |
Rats | 2 | 0.0 |
Uracil/metabolism | 3 | 27.0 |
*DNA Repair | 8 | 1.0 |
N-Glycosyl Hydrolases/*metabolism | 4 | 18.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
N-Glycosyl Hydrolases/*genetics | 4 | 14.0 |
Tumor Cells, Cultured | 3 | 0.0 |
*Variation (Genetics) | 2 | 0.0 |
DNA Primers | 4 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Cell Nucleus/enzymology | 2 | 2.0 |
Hela Cells | 6 | 0.0 |
*Mutation | 2 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Models, Molecular | 2 | 0.0 |
5-Methylcytosine | 2 | 9.0 |
Base Pair Mismatch | 2 | 1.0 |
N-Glycosyl Hydrolases/genetics/*metabolism | 3 | 27.0 |
Open Reading Frames | 2 | 0.0 |
Point Mutation | 3 | 0.0 |
Substrate Specificity | 5 | 0.0 |
*DNA Methylation | 2 | 0.0 |
Adult | 4 | 0.0 |
Aged | 2 | 0.0 |
Middle Aged | 2 | 0.0 |
Enterovirus/genetics/*isolation & purification | 2 | 100.0 |
Reagent Kits, Diagnostic | 2 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction/*methods | 2 | 3.0 |
Sensitivity and Specificity | 2 | 0.0 |
Polymerase Chain Reaction/*methods | 3 | 0.0 |
RNA, Viral/*analysis | 2 | 3.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
N-Glycosyl Hydrolases/antagonists & inhibitors/*metabolism | 2 | 66.0 |
Oligonucleotides/metabolism | 2 | 2.0 |
Exons | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Comparative Study | 4 | 0.0 |
N-Glycosyl Hydrolases/*genetics/isolation & purification/metabolism | 2 | 66.0 |
Recombinant Proteins/isolation & purification/metabolism | 2 | 1.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Simplexvirus/*enzymology | 2 | 25.0 |
*DNA Damage | 2 | 0.0 |
